Literature DB >> 2564292

A local circuit neocortical synapse that operates via both NMDA and non-NMDA receptors.

A M Thomson1, D Girdlestone, D C West.   

Abstract

1. In slices of rat neocortex, spike triggered averaging was employed to record in one neurone the excitatory postsynaptic potential (e.p.s.p.) generated by a spike in another, neighbouring neurone. When recorded at different membrane potentials, some of these e.p.s.ps exhibited a voltage relation typical of neuronal responses to N-methyl-D-aspartate (NMDA). 2. Selective NMDA antagonists reduced the amplitude of these e.p.s.ps, but had little effect on their early rising phase. In contrast, a less selective excitatory amino acid antagonist reduced all phases of the e.p.s.p. 3. By analyzing single axon e.p.s.ps we have been able to establish that the synaptic input to one cortical cell, delivered by a single presynaptic cortical cell, operates simultaneously via NMDA and non-NMDA amino acid receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564292      PMCID: PMC1854375          DOI: 10.1111/j.1476-5381.1989.tb11831.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Slow excitatory postsynaptic currents mediated by N-methyl-D-aspartate receptors on cultured mouse central neurones.

Authors:  I D Forsythe; G L Westbrook
Journal:  J Physiol       Date:  1988-02       Impact factor: 5.182

Review 2.  Excitatory amino acid transmitters.

Authors:  J C Watkins; R H Evans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

3.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5.

Authors:  R G Morris; E Anderson; G S Lynch; M Baudry
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

4.  Magnesium gates glutamate-activated channels in mouse central neurones.

Authors:  L Nowak; P Bregestovski; P Ascher; A Herbet; A Prochiantz
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

Review 5.  Amino acid neurotransmitters and new approaches to anticonvulsant drug action.

Authors:  B Meldrum
Journal:  Epilepsia       Date:  1984       Impact factor: 5.864

6.  Ketamine-xylazine anaesthesia blocks consolidation of ocular dominance changes in kitten visual cortex.

Authors:  J P Rauschecker; S Hahn
Journal:  Nature       Date:  1987 Mar 12-18       Impact factor: 49.962

7.  Synaptic actions of single interneurones mediating reciprocal Ia inhibition of motoneurones.

Authors:  E Jankowska; W J Roberts
Journal:  J Physiol       Date:  1972-05       Impact factor: 5.182

8.  A magnesium-sensitive post-synaptic potential in rat cerebral cortex resembles neuronal responses to N-methylaspartate.

Authors:  A M Thomson
Journal:  J Physiol       Date:  1986-01       Impact factor: 5.182

9.  CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity.

Authors:  J Davies; R H Evans; P L Herrling; A W Jones; H J Olverman; P Pook; J C Watkins
Journal:  Brain Res       Date:  1986-09-10       Impact factor: 3.252

  9 in total
  3 in total

1.  Activity-dependent properties of synaptic transmission at two classes of connections made by rat neocortical pyramidal axons in vitro.

Authors:  A M Thomson
Journal:  J Physiol       Date:  1997-07-01       Impact factor: 5.182

2.  NMDA and non-NMDA receptors contribute to synaptic transmission between the medial geniculate body and the lateral nucleus of the amygdala.

Authors:  X F Li; R Phillips; J E LeDoux
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

3.  Prominent facilitation at beta and gamma frequency range revealed with physiological calcium concentration in adult mouse piriform cortex in vitro.

Authors:  Marie Gleizes; Simon P Perrier; Caroline Fonta; Lionel G Nowak
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.